Fatty liver indices in obese and non-obese patients with dyslipidemia

  • Milena Peličić Student
  • Milica Petrović Faculty of Medicine University of Belgrade
  • Ljiljana Popović Clinic for Endocrinology, Diabetes and Metabolic Diseases; Faculty of Medicine University of Belgrade
DOI: https://doi.org/10.5937/mp74-39378
Keywords: obesity, FLI, TyG, NAFLD

Abstract


Introduction: The obesity pandemic is closely related to the growing prevalence and severity of fatty liver. Metabolic imbalances – insulin resistance and dyslipidemia – are cited as the main factors that create the basis for its occurrence and progression to non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and other complications (cirrhosis, hepatocellular carcinoma).

Aim: The aim of the study was to compare the FLI and TyG indices within two groups of patients, obese and non - obese, as well as to determine their interrelationship and correlation with other laboratory parameters.

Material and methods: The study included 62 patients, divided into two groups: obese and non-obese, equally represented (50%; 31). Anthropometric measurements and all laboratory tests of blood samples taken after 12 – 14 hours of night fasting were performed at the Clinic for Endocrinology, Diabetes and Metabolic Diseases UCCS. The FLI and TyG indices were calculated using appropriate algorithmic calculators.

Results: The median of FLI in the obese patients was 86.4 and in the non-obese 13.7 (p<0.001). The average value of TyG in obese was 5.0 ± 0.3 and in the non-obese 4.7  ± 0.3 (p<0.001). Obese patients were significantly older, had higher BMI and waist circumference (p<0.01). Non-obese patients had higher values of total cholesterol, HDL and LDL (p<0.05), while tryglicerides were higher in obese patients (p=0.01). The interrelationship as well as the correlation between indices  and other laboratory parameters was of a significant medium degree (p<0.05), except in the case of HDL, where a moderate degree of negative correlation was observed.

Conclusion: Fatty liver indices were significantly higher in obese patients. Total cholesterol, HDL and LDL were higher in non-obese and tryglicerides were higher in obese patients. The interrelationship and correlations between the indices and other laboratory parameters were moderately positive. Lower HDL values resulted in higher indices values.

Key words: obesity, FLI, TyG, NAFLD.

References


  1. Iwasaki Y, Shiina K, Matsumoto C, Nakano H, Fujii M, Yamashina A et al. Correlation of the Fatty Liver Index with the Pathophysiological Abnormalities Associated with Cardiovascular Risk Markers in Japanese Men without any History of Cardiovascular Disease: Comparison with the Fibrosis-4 Score. J Atheroscler Thromb. 2021; 28(5):524-534.

  2. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione Aet al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006; 6:33.

  3. Zhang S, Du T, Zhang J, Lu H, Lin X, Xie J et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017; 16(1):15.

  4. Mundi MS, Velapati S, Patel J, Kellogg TA, Abu Dayyeh BK, Hurt RT. Evolution of NAFLD and Its Management. Nutr Clin Pract. 2020; 35(1):72-84.

  5. Kitade H, Chen G, Ni Y, Ota T. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. Nutrients. 2017; 9(4):387.

  6. Krawczyk M, Bonfrate L, Portincasa P. Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol. 2010; 24(5):695-708.

  7. Zhang T, Chen J, Tang X, Luo Q, Xu D, Yu B. Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis. Lipids Health Dis. 2019; 18(1):223.

  8. Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2019; 92:82-97.

  9. Li Y, Chen Y, Tian X, Zhang S, Jiao J. Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD). Diabetes Metab Syndr Obes. 2021; 14:2029-2039.

  10. Caballero B. Humans against Obesity: Who Will Win? Adv Nutr. 2019; 10(suppl_1):S4-S9.

  11. Huang XJ, Choi YK, Im HS, Yarimaga O, Yoon E, Kim HS. Aspartate Aminotransferase (AST/GOT) and Alanine Aminotransferase (ALT/GPT) Detection Techniques. Sensors. 2006; 6(7):756-82.

  12. Mao Y, Qi X, Xu W, Song H, Xu M, Ma W et al. Serum gamma-glutamyl transferase: a novel biomarker for coronary artery disease. Med Sci Monit. 2014; 20:706-10.

  13. Tyrovolas S, Panagiotakos DB, Georgousopoulou EN, Chrysohoou C, Skoumas J, Pan W et al. The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study. Therap Adv Gastroenterol. 2019; 12:1756284819858039.

  14. Motamed N, Sohrabi M, Ajdarkosh H, Hemmasi G, Maadi M, Sayeedian FS et al. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J Gastroenterol. 2016; 22(10):3023-30.

  15. Tutunchi H, Naeini F, Mobasseri M, Ostadrahimi A. Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study. Clin Nutr ESPEN. 2021; 44:483-487.

Published
2024/02/28
Issue
Vol. 74 No. 6 (2023): Medicinski podmladak
Section
Original Scientific Paper